INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-2036497889-lab-computer-research]( "RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters")
RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It MattersExplore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.
-
![GettyImages-1356722386 driving]( "Why Is Clinical Trial Patient Travel So Important?")
Why Is Clinical Trial Patient Travel So Important?Removing travel barriers in clinical trials ensures broader access, diverse participation and stronger results, benefiting both patients and researchers alike.
-
![GettyImages-1346651718-decentralized-doctor-patient-computer-remote]( "The Hidden Healthcare Benefits That Home Trial Support Provides")
The Hidden Healthcare Benefits That Home Trial Support ProvidesExamine how Home Trial Support (HTS) enhances both patient and caregiver safety and well-being, while alleviating pressures on sites and generating greater ROI for sponsors.
-
![Korio Dosing Configuration Demo]( "Korio RTSM Platform: Dosing Configuration Demo")
Korio RTSM Platform: Dosing Configuration DemoProtocols evolve — and Korio is built to evolve with them. In this demo, see how users can easily add new doses, configure dose use rules, and define logic for dose adjustments based on visit history or other criteria.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
5 Questions To Ask Before Selecting A Randomization Partner5/12/2026
Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.
-
Human Abuse Potential: Study Management5/1/2026
Learn how human abuse potential studies are strengthened through thoughtful, targeted volunteer selection, clearly defined inclusion and exclusion criteria, and disciplined study oversight.
-
Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular Endpoints6/9/2026
Reduce operational risk in ophthalmic trials with point-of-need execution. Discover how mobile clinics, specialized teams, and single-call accountability protect endpoint quality and study timelines.
-
Do You Know Today, What Your Trial Will Spend Tomorrow?7/13/2026
Fragmented data and outdated forecasting can derail trial budgets. Real-time financial and operational insights improve accuracy and spending control.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1358835459-computer-gear-digital-hands]( "Elosity: Next-Generation RTSM")
With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
![rtsm-clinical-trial-tech-GettyImages-872024272]( "PULSE: Empowering Every Phase of Your Clinical Journey")
A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.
-
![GettyImages-1083316464_eye]( "Your Top Partner For Ophthalmic Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
![Clinical Trials]( "TrialScope Disclose")
With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
